I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lesokhin, AM
206
results:
Search for persons
X
Format
Online (204)
Print (2)
Mediatypes
Books (2)
Articles (Online) (152)
Bookchapter (Online) (1)
OpenAccess-fulltext (51)
Sorted by: Relevance
Sorted by: Year
?
1
EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PA..:
Raje, N
;
Leleu, X
;
Lesokhin, A
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S406-S407 , 2023
Link:
https://doi.org/10.1016/..
?
2
Enhancing T‐cell responses to GCB‐like lymphomas with immun..:
Serganova, I.
;
Bucktrout, R.
;
Isshiki, Y.
...
Hematological Oncology. 41 (2023) S2 - p. 280-280 , 2023
Link:
https://doi.org/10.1002/..
?
3
ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANT..:
Mohty, M
;
Tomasson, M
;
Arnulf, B
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S404-S405 , 2023
Link:
https://doi.org/10.1016/..
?
4
EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSE..:
Nooka, A
;
Lesokhin, A
;
Mohty, M
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S405 , 2023
Link:
https://doi.org/10.1016/..
?
5
P886: AFRICAN AMERICAN PATIENTS WITH SMOLDERING MULTIPLE MY..:
Akhlaghi, T.
;
Maclachlan, K.
;
Korde, N.
...
HemaSphere. 6 (2022) - p. 778-779 , 2022
Link:
https://doi.org/10.1097/..
?
6
P897: UPDATED RESULTS FROM THE ONGOING PHASE 1 STUDY OF ELR..:
Dalovisio, A.
;
Bahlis, N.
;
Raje, N.
...
HemaSphere. 6 (2022) - p. 788-789 , 2022
Link:
https://doi.org/10.1097/..
?
7
A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN..:
Lesokhin, AM
;
Arnulf, B
;
Niesvizky, R
...
Hematology, Transfusion and Cell Therapy. 44 (2022) - p. S245-S246 , 2022
Link:
https://doi.org/10.1016/..
?
8
P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL..:
Lin, Y.
;
Martin, T.
;
Berdeja, J. G.
...
HemaSphere. 6 (2022) - p. 851-852 , 2022
Link:
https://doi.org/10.1097/..
?
9
S177: EVALUATING SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKE..:
Akhlaghi, T.
;
Maclachlan, K.
;
Korde, N.
...
HemaSphere. 6 (2022) - p. 78-79 , 2022
Link:
https://doi.org/10.1097/..
?
10
EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL ..:
Solh, M
;
Bahlis, NJ
;
Raje, NS
...
Hematology, Transfusion and Cell Therapy. 43 (2021) - p. S195-S196 , 2021
Link:
https://doi.org/10.1016/..
?
11
Upfront plerixafor plus G-CSF versus cyclophosphamide plus ..:
Afifi, S
;
Adel, N G
;
Devlin, S
...
Bone Marrow Transplantation. 51 (2016) 4 - p. 546-552 , 2016
Link:
https://doi.org/10.1038/..
?
12
CD34-selected allogeneic hematopoietic stem cell transplant..:
Koehne, G.
;
Devlin, S.
;
Landau, H.
...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e280 , 2015
Link:
https://doi.org/10.1016/..
?
13
A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic S..:
Koehne, G.
;
Landau, H.
;
Hassoun, H.
...
Biology of Blood and Marrow Transplantation. 17 (2011) 2 - p. S286 , 2011
Link:
https://doi.org/10.1016/..
?
14
Prevalence and impact of diabetes on survival of patients w..:
Shah, Urvi A.
;
Moshier, Erin
;
Derkach, Andriy
...
Blood Advances. 8 (2024) 1 - p. 236-247 , 2024
Link:
https://doi.org/10.1182/..
?
15
Nivolumab and daratumumab combination regimens for the trea..:
Abdallah, Al-Ola
;
Lesokhin, Alexander
;
Wrobel, Tomasz
...
Frontiers in Hematology. 2 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
1-15